Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.19.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows ($ in thousands):

 

    Three Months Ended March 31,  
    2019     2018  
Research and Development   $ 299     $ 573  
General and Administrative     505       1,175  
Total   $ 804     $ 1,748  

Schedule of Equity Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at March 31, 2019:

 

    Awards Reserved for Issuance     Awards Issued     Awards
Available for Grant
 
2013 Equity Compensation Plan (in thousands)     22,421 *     18,684 **     3,737  
                         

 

* Increased by 4,532 thousand on January 1, 2019, representing 4% of the total number of shares of commons stock outstanding on December 31, 2018.
** Includes both stock grants and option grants

Schedule of Stock Option Activity

The following table summarizes the Company’ stock option activity and related information for the period from December 31, 2018 to March 31, 2019 (options in thousands):

 

    Number of
Options
    Weighted Average Exercise Price     Weighted Average Contractual
Term in Years
 
Outstanding at December 31, 2018     13,457     $ 1.13       6.2  
Granted     3,220     $ 1.05          
Exercised     -                  
Forfeited     (71 )   $ 1.31          
Cancelled     -                  
Expired     (34 )   $ 2.33          
Outstanding at March 31, 2019     16,572     $ 1.11       6.7  

Schedule of Share Based Payment Assumptions

The following weighted-average assumptions were used to calculate share-based compensation:

 

    For the Three Months ended March 31,  
    2019     2018  
Volatility     110.85% - 111.34 %       105.85% - 107.95 %
Risk-free interest rate     2.46% - 2.65 %     2.29% - 2.71 %
Dividend yield     0.0 %     0.0 %
Expected life     6.0 years       6.0 years